July 28, 2009 – Bioheart Inc. today said the FDA cleared a phase I clinical trial for MyoCell SDF-1 (Stromal Derived Factor - 1) to treat congestive heart failure.

July 28, 2009 – Sanofi-aventis said today MULTAQ (dronedarone) 400 mg tablets are now available in pharmacies in the United States.

July 28, 2009 – Onset Medical Corporation said today it received CE mark approval to begin marketing the SoloPath Endovascular Access Catheter in the European Union.

July 28, 2009 – The American College of Cardiology (ACC) is taking a leading role in healthcare reform in partnership with patients, lawmakers and payers. The ACC said it is setting a new standard for healthcare delivery, one that centers on increasing the quality of care and ensuring greater patient access and value.

July 28, 2009 – Researchers may be able to predict future severe cardiac events in patients with known, stable coronary artery disease (CAD) using coronary calcium scoring, according to a study published today in the online edition of Radiology.

July 27, 2009 - TeraRecon Inc., a leader in advanced visualization and decision support solutions for medical imaging and a partner of the Society of Cardiovascular Computed Tomography (SCCT), and Agfa HealthCare released the first cardiac CT review and reporting solution which conforms to the SCCT’s published guidelines* for cardiac CT interpretation.

July 27, 2009 – Prescient Medical Inc. received the prestigious 2009 North American Product Innovation of the Year Award from Frost & Sullivan for Atherosclerosis Lesion Management, for its efforts to reduce deaths related to heart attacks using the vProtect Luminal Shield.

July 27, 2009 – Terumo Cardiovascular Systems said Friday it initiated a phase II clinical trial for the Anaconda AAA (abdominal aortic aneurysm) stent graft system in the U.S.

July 27, 2009 – Carestream Health Inc. today launched a new Web-based cardiology PACS that offers a single integrated platform for diagnosis, image review and reporting for echocardiography, cardiac catheterization and nuclear cardiology procedures as well as electrocardiogram management.

July 24, 2009 – Michael Jones has become the world’s first recipient of adult cardiac stem cells to treat congestive heart failure. Jones’ infusion on July 17 marks the world’s first phase-one, FDA-approved clinical trial using c-kit-positive cardiac stem cells to treat heart disease being conducted by a team of University of Louisville physicians at Jewish Hospital.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now